Omega Diagnostics Share Discussion Threads

[snake_pleskin] 31/8/2007 18:37

Thats true but i didnt i paid 1p. Have 500k had i think that converts to just 12500 now. So im buying more monday.

[guman] 31/8/2007 18:35

s_p
not much if you had paid 110 year ago.

[snake_pleskin] 31/8/2007 18:22

Smiler £1.... Plus..in my opinion.

[smiler 0] 31/8/2007 17:53

tinker, best guess on share price say in 6/12 months ?

[tinker tailor] 31/8/2007 17:47

Directors have bought in as well which shows me more confidence in this company.


Omega Diagnostics Directors' Dealings


RNS Number:1021D
Omega Diagnostics Group PLC
31 August 2007


Omega Diagnostics Group PLC

31 August 2007


Omega Diagnostics Group PLC ("Omega" or "the Company")

Directors Shareholdings & Issue of Equity

Omega Diagnostics Group PLC announces that following its share consolidation and
capital reorganization (the "Share Consolidation" and the "Capital
Reorganisation" respectively), 9,684,470 new Ordinary Shares of 4 pence each ("
New Ordinary Shares") have today been admitted to AIM (the "First Admission").
Application has been made for a further 5,191,223 New Ordinary Shares to be
admitted to AIM, which is expected to become effective on 3 September 2007 (the
"Second Admission").

As part of the placing related to the acquisitions of Genesis Diagnostics
Limited and Cambridge Nutritional Sciences Limited announced on 6 August 2007
and approved by shareholders at the EGM of the Company yesterday
(the "Placing"), David Evans, Non-Executive Chairman and Andrew Shepherd,
Chief Executive Officer of the Company have today purchased New Ordinary Shares
at the placing price of 30p per share. The number of New Ordinary Shares
purchased by each Director and their resultant holding of New Ordinary Shares in
the Company is set out below:

No. of New Interest in New Interest in total Interest in total
Ordinary Shares Ordinary Shares issued share issued share
purchased as part following the capital following capital following
of the Placing Placing First Admission Second Admission

David Evans, Non-Executive 100,000 100,000 1.03% 0.67%
Chairman

Andrew Shepherd, Chief 100,000 902,568 9.32% 6.07%
Executive Officer


In addition, in accordance with the details of the Share Consolidation set out
in the Admission Document published on 3 August 2007, David Evans yesterday
purchased 25 non-consolidated Ordinary Shares of 1p each in the Company ("Old
Ordinary Shares") at the price of 1p per Old Ordinary Share, being the par value
of the Old Ordinary Shares. This was in order to increase the issued share
capital of the Company to a number divisible by 40 prior to the Share
Consolidation becoming effective. Following this transaction, David Evans held
less than 0.01% of yesterday's issued share capital.

Following the implementation of the Share Consolidation, these 25 Old Ordinary
Shares are now a fraction of a New Ordinary Share and have been aggregated with
the fractions of New Ordinary Shares to which other fractional shareholders of
the Company are entitled so as to form full New Ordinary Shares and will be sold
in the market for the benefit of the Company. In total there are 19 New
Ordinary Shares resulting from fractional entitlements to New Ordinary Shares.

The issue of 25 Old Ordinary Shares of 1p each to David Evans has resulted in
one additional New Ordinary Share following aggregation with other fractional
entitlements after the Share Consolidation. Application has been made for this
additional New Ordinary Share to be admitted to trading on AIM, which is
expected to become effective on 6 September 2007. Following Admission of this
additional New Ordinary Share the Company's issued share capital will consist of
14,875,694 New Ordinary Shares.

Contacts:

Omega Diagnostics Group PLC
Tel: [phone]

Andrew Shepherd, Chief Executive
Kieron Harbinson, Finance Director
www.omegadiagnostics.com

Landsbanki Securities (UK) Limited
Nominated Adviser & Broker
Tel: [phone]

Thilo Hoffmann/Simon Brown, Corporate Finance

Parkgreen Communications Limited
Ben Knowles
T. 020 7479 7933
Mob. [phone]
[e-mail]

[tinker tailor] 31/8/2007 16:01

Some lucky person picked up a few.I remember when another stock came onto the market recently,which was only a shell,but have very few shares available to trade in the market.It went up 300%.

Monday could be a very interesting day if the buyers descend and the news today does make this a very exciting opportunity.

[tinker tailor] 31/8/2007 11:02

My broker tells me Monday.I tell him I want some today because those results should lift ODX considerably.No dice.

[snake_pleskin] 31/8/2007 10:58

Starting to tick up now, these will be trading at £1 plus by the end september.

[tinker tailor] 31/8/2007 10:08

I want to buy more after reading through those two sets of results but as everyone says cannot until the brokers sort themselves out.

[snake_pleskin] 31/8/2007 08:51

Therers no trades because the brokers have not got themselves sorted yet..My holding is not registering in selftrade and the symbol is not recognised..probably the same elsewhere..It is in tdwaterhouse ive tried there as well.

[smiler 0] 31/8/2007 08:43

About time !!

[snake_pleskin] 31/8/2007 08:30

Good set of results, both acquisitions are profitable, we should see a nice increase from here.

[gadg3t] 31/8/2007 08:27

Omega Diagnostics Group PLC
31 August 2007


31 August 2007

Omega Diagnostics Group PLC ('the Company')


Omega Diagnostics Group PLC announces that further to yesterday's Extraordinary
General Meeting at which approval was given for the acquisition of Genesis
Diagnostics Ltd ('Genesis') and Cambridge Nutritional Sciences Ltd ('CNS'), the
unaudited trading results of Genesis and CNS for the eight months ended 30 June
2007 are provided below. These trading results will not form part of the
trading results for Omega Diagnostics Group PLC for its year ended 31 March
2008, since it is only the post-acquisition trading results of Genesis and CNS
that will be included.

The figures below are provided as guidance only to shareholders of the trading
performance of Genesis and CNS in the year to date. Included within the Genesis
results for the eight months to 30 June 2007 is directors' remuneration of
£143,955 (12 months to 31 October 2006: £195,258). These costs cover the
remuneration of the two vendor directors, Dr Mike Walker and Mrs Irene Walker.
On completion of the acquisitions, these costs will cease with immediate effect
although Dr Mike Walker will be appointed a non-executive director of the
Company at completion on an annual fee of £15,000.

[snake_pleskin] 31/8/2007 08:06

These now will start moving only 5 million in free hold.. Any buying and they will fly.

[tinker tailor] 30/8/2007 13:18

Omega Diagnostics Result of EGM


RNS Number:0145D
Omega Diagnostics Group PLC
30 August 2007


30 August 2007

Omega Diagnostics Group plc

Results of Extraordinary General Meeting

Omega Diagnostics Group plc announces that at the Extraordinary General Meeting
of the company held today, all resolutions were duly passed.


Applications have been made to admit 14,875,693 New Ordinary Shares to trading
on AIM. It is expected that admission for 9,684,470 New Ordinary Shares becomes
effective on 31 August 2007 (the First Admission Shares) and that admission for
5,191,223 New Ordinary Shares becomes effective on 03 September 2007 (the Second
Admission Shares). Following the Second Admission the Company's issued share
capital will consist of 14,875,693 New Ordinary Shares with a nominal value of 4
pence each.



Following the capital reorganization and consolidation admission to AIM and
trading in the 123,245,615 Existing Ordinary Shares of 1 pence each will be
cancelled after 30 August 2007 and trading in the New Ordinary Shares of 4 pence
each will commence on 31 August 2007.

[tinker tailor] 23/8/2007 21:45

Well my trade was matched by a seller so evens stevens today.

[smiler 0] 23/8/2007 13:32

I still have a few of these, I can not understand why they are so low with such good prospects ! :(

[tinker tailor] 23/8/2007 09:46

I have picked up a few and I mean a few as funds all tied up at present.Seems as though they are delaying all trades.

[tinker tailor] 23/8/2007 09:24

gad I think you are correct.I have had a quick look and this does appear at first glance to be interesting.I notice the Directors have a lock in period too which says to me that they do have faith.The purchase of the two other companies should open combined opportunities and also cost savings as time goes on.

[power talker] 23/8/2007 08:16

Gadg3t i totally agree with you..Not long to wait before the consolidation and company update..We then should see some value here.

[gadg3t] 23/8/2007 08:01

As I have said ODX is still below the Radar !! I still think this share could do very well !!

[power talker] 23/8/2007 01:47

I hold 550,000 of these,it is difficult to estimate a price as on the 31st of this month there is a 40 for 1 consolidation. So my shares convert to approx 13,700.

The good thing about Omega and their buying of genesis and cambridge nutritional, i believe is the ability they will then have to market new products in over 100 countries(Omega already has this distribution network in place from their existing business).

Bear in mind that genesis and Cambridge are profitable concerns and that only 5 million shares are effectively in circulation after the re-organisation. Any good news will drive the new shares over £1. That in effect is a 150% increase from here.

I also think news will be forthcoming after this date, till then its a buyers market and they are going cheap.All in my opinion of course.

[tinker tailor] 22/8/2007 23:26

PT are you invested here already?What do you see them going to in the short term and why?